Skip to main content

Table 1 Characteristics of subjects at baseline that underwent full analysis

From: Preventive effect of irsogladine or omeprazole on non-steroidal anti-inflammatory drug-induced esophagitis, peptic ulcers, and small intestinal lesions in humans, a prospective randomized controlled study

 

Irsogladine group

Omeprazole group

p value

No. of subjects

16

16

 

Age (years) (mean ± SD)

25±4

25±4

NS

Sex (M/F)

10/6

11/5

NS

H. pylori infection status (+/−)

1/15

1/15

NS

Fecal hemoglobin concentration (mg/dL) (mean ± SD)

14.1 ± 2.0

14.4 ± 1.2

NS

Number of mucosal breaks (mean ± SD)

0.3 ± 0.8

0.1 ± 0.3

NS

Number of reddened lesions (mean ± SD)

0.2 ± 0.4

0.6 ± 0.8

NS

Number of sites of bleeding (mean ± SD)

0.0 ± 0.0

0.1 ± 0.3

NS

  1. NS = not significant.